Search

Your search keyword '"Abutidze, Akaki"' showing total 117 results

Search Constraints

Start Over You searched for: Author "Abutidze, Akaki" Remove constraint Author: "Abutidze, Akaki"
117 results on '"Abutidze, Akaki"'

Search Results

1. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

2. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024

4. Integrase Strand Transfer Inhibitor–Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium.

5. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

9. The Management of Patients at High Risk of Serious COVID-19 Disease: Optimising the Patient Pathway in the Middle East, Africa, and Eastern Europe

10. Differences in integrated assessment and management of non‐communicable diseases (NCDs) for people with HIV across the WHO European region.

11. Treatment of hepatitis C in primary health care in the country of Georgia

12. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia

14. Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-December 2022

20. Five years of progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-October 2021

21. Treatment of hepatitis C in primary healthcare in the country of Georgia

22. Optimal screening and linkage to care model to achieve hepatitis C elimination targets in Georgia

23. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

24. Treatment of hepatitis C in primary healthcare in the country of Georgia

25. Five years of progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-October 2021

30. Characteristics and outcomes of hospitalized adult COVID-19 patients in Georgia

32. Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-October 2019

33. Management of hepatitis C in primary healthcare in the country of Georgia

34. FRI401 - Optimal screening and linkage to care model to achieve hepatitis C elimination targets in Georgia

35. Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-October 2019

36. STD866055 Supplemental Material - Supplemental material for Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia

37. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015–March 2018

39. THU-146-LDV/SOF/RBV is an effective first-line DAA regimen as well as retreatment option for RF1_2k/1b patients within Georgian national hepatitis C elimination program

40. THU-186-Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-August 2018

41. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015–March 2018.

43. Feasibility and effectiveness of routine HIV screening in emergency setting in Georgia

47. Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program

Catalog

Books, media, physical & digital resources